BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,450,000 | +11.7% | 19,020,000 | +13.1% | 0.01% | +25.0% |
| Q2 2023 | $16,524,000 | -7.1% | 16,822,000 | -3.0% | 0.00% | -20.0% |
| Q1 2023 | $17,786,000 | -9.8% | 17,336,000 | -6.7% | 0.01% | -16.7% |
| Q4 2022 | $19,724,000 | +6.0% | 18,585,000 | -0.6% | 0.01% | 0.0% |
| Q3 2022 | $18,612,000 | -13.2% | 18,695,000 | -13.7% | 0.01% | 0.0% |
| Q2 2022 | $21,438,000 | -31.5% | 21,655,000 | -30.8% | 0.01% | -25.0% |
| Q1 2022 | $31,300,000 | -6.1% | 31,315,000 | -1.7% | 0.01% | 0.0% |
| Q4 2021 | $33,317,000 | +2.5% | 31,864,000 | +0.7% | 0.01% | -11.1% |
| Q3 2021 | $32,508,000 | +15.6% | 31,639,000 | +16.6% | 0.01% | +28.6% |
| Q2 2021 | $28,124,000 | +395.6% | 27,139,000 | +389.4% | 0.01% | +250.0% |
| Q1 2021 | $5,675,000 | +1147.3% | 5,545,000 | +1207.8% | 0.00% | – |
| Q4 2020 | $455,000 | +2.2% | 424,000 | 0.0% | 0.00% | – |
| Q3 2020 | $445,000 | -30.3% | 424,000 | -18.5% | 0.00% | – |
| Q2 2020 | $638,000 | -12.7% | 520,000 | -25.7% | 0.00% | – |
| Q1 2020 | $731,000 | +36450.0% | 700,000 | +34900.0% | 0.00% | – |
| Q3 2019 | $2,000 | -99.2% | 2,000 | -99.2% | 0.00% | – |
| Q4 2018 | $248,000 | -99.3% | 250,000 | -99.3% | 0.00% | -100.0% |
| Q4 2017 | $34,171,000 | +28.7% | 34,300,000 | +31.2% | 0.02% | +15.4% |
| Q3 2017 | $26,542,000 | – | 26,150,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |